Pharmaceutical Working Group Go back »

The Pharmaceutical Working Group represents nearly 40 international pharmaceutical manufacturing companies operating in China. The working group engages in a constructive dialogue with all relevant government agencies at national, provincial, and local levels and shares its expertise and international best practices with Chinese authorities. In particular, the working group has established a sound communication channel with the Chinese medical authorities and regulators. It encourages government policies that support the creation of a sustainable environment, which foster innovation and the healthy growth of the pharmaceutical industry as a whole, while improving patients’ access to affordable, innovative and high-quality medicines. The Pharmaceutical Working Group also offers recommendations based on experience accumulated during decades of healthcare reform in European countries that may further support the development of China’s healthcare system.

  • Chair: Mr Raphael de Garnier des Garets, Sanofi
  • Vice Chair: Ms Carol Liu, Boehringer Ingelheim; Ms Michelle Zhao, Bristol-Myers Squibb; Ms Minglei Zhu, Lundbeck

You are currently not a member of this Working Group.

Join this Working Group

Chamber contact
Lin Shi
Lin Shi

Shanghai

+86 (21) - 6385 2023 ext.110
Click to email

Lin Shi
Lin Shi

Beijing

+86 (21) - 6385 2023 ext.110
Click to email

Quick jump to:

Back to overview